Novartis
Officials from Novartis recently report on new developments
Published in Lab Law Weekly, March 2nd, 2007
This trend article is an immediate alert from NewsRx to identify the most recent news developments at Novartis.
Report 1: Novartis has received a positive opinion supporting European Union regulatory approval for Lucentis (ranibizumab) as a new treatment option for patients with the "wet" form of age-related macular degeneration (AMD), the leading cause of severe vision loss in people over age 50 in the western world.
The Committee for Medicinal Products for Human Use (CHMP), which reviews drug applications for all 25 countries in the European Union as well as Iceland...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Law Weekly
Source: Lab Law Weekly (2007-03-02)
More Articles from Lab Law Weekly
- Advocacy
IBM calls on Congress to act on genetic nondiscrimination legislation - Business & Finance
Bristol-Myers Squibb reports loss of $0.07 per share - Business & Finance
Caraco Pharmaceutical Laboratories reports record sales and profits - Business & Finance
Corning announces fourth-quarter and full-year results - Business & Finance
Sinovac clarifies position on restructuring with Chinese subsidiary, reports PRD approvals - Business Update
DaVita announces completion of government investigation - More from this issue of Lab Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
